Oncotarget

Research Papers:

Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494

Yifeng Bai, Yanqin Sun, Juan Peng, Hongzhan Liao, Hongyi Gao, Ying Guo and Linlang Guo _

PDF  |  HTML  |  Supplementary Files  |  Order a Reprint

Oncotarget. 2014; 5:7760-7775. https://doi.org/10.18632/oncotarget.2305

Metrics: PDF 1542 views  |   HTML 1443 views  |   ?  


Abstract

Yifeng Bai1,2,*, Yanqin Sun1,3,*, Juan Peng1,4, Hongzhan Liao5, Hongyi Gao1,6, Ying Guo7 and Linlang Guo1

1 Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China

2 Department of Oncology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, China

3 Department of Pathology, School of Basic Medicine Science, Guangdong Medical College, Dongguan, China

4 Department of Pathology, the Third Affiliated Hospital Of Guangzhou Medical University, Guangzhou, China

5 Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China

6 Department of Pathology, Guangdong Women and Children Hospital, Guangzhou, China

7 Department of Organ Transplantation, Zhujiang Hospital, Southern Medical University, Guangzhou, China

* These authors contributed equally to this work

Correspondence:

Linlang Guo, email:

Ying Guo, email:

Keywords: SCGN, miR-494, SCLC, chemoresistance

Received: April 01, 2014 Accepted: August 03, 2014 Published: August 04, 2014

Abstract

Secretagogin (SCGN) has recently been identified to play a crucial role in cell apoptosis, receptor signaling and differentiation. However, its clinical significance and functional roles in SCLC chemoresistance remain unknown. Here we examined the expression of SCGN in clinical samples from SCLC patients and evaluated its relation with clinical prognosis. Then up and down-regulation of SCGN were carried out in SCLC cell lines to assess its influence on chemoresistance. Furthermore, luciferase reporter assay was used to evaluate whether SCGN is a novel direct target of miR-494. Our results revealed that elevated expression of SCGN was correlated with the poorer prognosis of SCLC patients and the more significant correlation with chemosensitivity. We also found that knockdown of SCGN expression in H69AR and H446AR cells increased chemosensitivity via increasing cell apoptosis and cell cycle arrest of G0/G1 phase, while over-expression of SCGN reduced chemosensitivity in sensitive H69 and H446 cells. SCGN as a novel target of miR-494 by luciferase reporter assay, up-regulation of miR-494 can sensitize H69AR cells to chemotherapeutic drugs. These results suggest SCGN is involved in the chemoresistance of SCLC under the regulation of miR-494 and may be a potential biomarker for predicting therapeutic response in treatment SCLC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 2305